James B. Renacci bought Haemonetics Corporation (NYSE: HAE)
James B. Renacci (R-OH), a U.S. Representative, has disclosed 6 trades in Haemonetics Corporation (HAE) since 2014, 4 purchases and 2 sales, worth an estimated $97K in disclosed volume (the midpoint of the dollar ranges members report, not exact amounts).
The trade highlighted here is a purchase: James B. Renacci bought $1,000 - $15,000 of Haemonetics Corporation (NYSE: HAE) on January 24, 2014. Since that trade, HAE is up +113.34% against the S&P 500 up +402.02%, an outperformance of -288.69%.
Across these filings, James B. Renacci has been a net buyer of HAE (a buy-to-sell ratio of 2.00). Each row in the table below links to that trade and its post-trade performance versus the market.
Data updated
James B. Renacci's HAE trades vs the price
HAE is up +113.34% since James B. Renacci bought on January 24, 2014, versus +402.02% for the S&P 500.
Performance since this trade
All James B. Renacci HAE trades
Estimated profit is shown for buys only, marked to the latest close. It is an estimate and does not net later sells, taxes, or fees.
James B. Renacci & HAE trading FAQ
Is it legal for James B. Renacci to trade Haemonetics Corporation (HAE) stock?
Yes. Members of Congress are allowed to trade individual stocks, including Haemonetics Corporation (HAE), but the STOCK Act of 2012 requires them to publicly disclose each transaction within 45 days. Quantellect tracks those disclosures; this page does not imply the trade was improper.
When did James B. Renacci buy HAE?
James B. Renacci disclosed a purchase of $1,000 - $15,000 of Haemonetics Corporation (HAE) on January 24, 2014, according to public STOCK Act filings.
How has HAE performed since James B. Renacci's trade?
Since James B. Renacci bought HAE on January 24, 2014, the stock is up +113.34%, versus +402.02% for the S&P 500 over the same period, an outperformance of -288.69%.
How many times has James B. Renacci traded HAE?
James B. Renacci has disclosed 6 HAE trades since 2014 (4 purchases and 2 sales). Every disclosed trade is listed on this page.
How soon must members of Congress disclose a trade?
Under the STOCK Act, members of Congress must publicly report a covered transaction within 45 days of the trade. Filings can still be delayed, amended, or contain errors.
Where can I see all congressional HAE trades?
Quantellect tracks every disclosed congressional trade in Haemonetics Corporation (HAE) on the Haemonetics Corporation congressional trading page, which aggregates filings across all members of Congress.
James B. Renacci's HAE tradesAll congressional filings for Haemonetics CorporationJames B. Renacci's full profile
Not investment advice. Congressional trading data is sourced from public STOCK Act disclosures, which are filed with a delay and may contain errors or be revised. Estimated prices and post-trade returns are derived algorithmically from public filings and end-of-day market data and describe historical activity, not a recommendation. Always do your own research and consult a licensed financial advisor before making investment decisions.